An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. [electronic resource]
Producer: 20030910Description: 711-21 p. digitalISSN:- 0002-9440
- Adenine -- analogs & derivatives
- Adenosine -- pharmacology
- Adenosine-5'-(N-ethylcarboxamide) -- pharmacology
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Cells, Cultured
- DNA-Binding Proteins -- agonists
- Endothelial Growth Factors -- metabolism
- Enzyme Inhibitors -- pharmacology
- Humans
- Intercellular Signaling Peptides and Proteins -- metabolism
- Lipopolysaccharides -- pharmacology
- Lipoproteins -- metabolism
- Lymphokines -- metabolism
- Macrophages, Peritoneal -- cytology
- Male
- Membrane Glycoproteins -- agonists
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- NF-kappa B -- metabolism
- Neovascularization, Physiologic
- Paclitaxel -- pharmacology
- Purinergic P1 Receptor Agonists
- Receptor, Adenosine A2A
- Receptors, Cell Surface -- agonists
- Receptors, Purinergic P1 -- metabolism
- Toll-Like Receptor 2
- Toll-Like Receptor 3
- Toll-Like Receptor 4
- Toll-Like Receptor 5
- Toll-Like Receptor 7
- Toll-Like Receptor 9
- Toll-Like Receptors
- Tumor Necrosis Factor-alpha -- genetics
- Up-Regulation -- physiology
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
- Vasodilator Agents -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.